Commentary (Friedland/Comis): Integration of Vinorelbine into Chemotherapy Strategies for Non-Small-Cell Lung Cancer

The treatment of advanced non-small-cell lung cancer has undergone incremental improvement over the last three decades of investigation. When this incremental history is reviewed, three distinct subdivisions emerge: (1) the minimal-activity era